Detalles de la búsqueda
1.
Icosapent ethyl therapy for very high triglyceride levels: a 12-week, multi-center, placebo-controlled, randomized, double-blinded, phase III clinical trial in China.
Lipids Health Dis
; 22(1): 71, 2023 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37301827
2.
mTORC1 signaling is crucial for regulatory T cells to suppress macrophage-mediated inflammatory response after acute myocardial infarction.
Immunol Cell Biol
; 94(3): 274-84, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26437770
3.
Adverse drug events associated with ibrutinib for the treatment of elderly patients with chronic lymphocytic leukemia: A systematic review and meta-analysis of randomized trials.
Medicine (Baltimore)
; 98(33): e16915, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31415440
4.
Short-Term Versus Long-Term Adverse Cardiovascular Outcomes Post Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Simple Meta-Analysis.
Diabetes Ther
; 10(4): 1487-1497, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31256352
5.
Sestrin2 Suppresses Classically Activated Macrophages-Mediated Inflammatory Response in Myocardial Infarction through Inhibition of mTORC1 Signaling.
Front Immunol
; 8: 728, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28713369
6.
Combination of D942 with curcumin protects cardiomyocytes from ischemic damage through promoting autophagy.
J Cardiovasc Pharmacol Ther
; 18(6): 570-81, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24057865
Resultados
1 -
6
de 6
1
Próxima >
>>